Stay updated on Dupilumab for AKC: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.

Latest updates to the Dupilumab for AKC: Efficacy Study Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page footer.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; this is a minor update with no visible changes to study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedAdded Andover Eye Associates as a collaborator/sponsor and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check65 days agoChange DetectedAdded a 'Show glossary' option and updated metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Minor wording/capitalization updates to FEAR Act data references and removal of older QC/version references (e.g., 'Last Update Submitted that met QC Criteria' and 'Revision: v3.3.4').SummaryDifference0.2%

- Check79 days agoChange DetectedThe page revision updated from v3.3.3 to v3.3.4, with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Dupilumab for AKC: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab for AKC: Efficacy Study Clinical Trial page.